US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on Feb. 18 for "Antigen binding molecules that bind LIGHT" (British Inventor)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,580, issued on Feb. 18, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain).

"Antigen binding molecules that bind LIGHT" was invented by Steve Holmes (Altrincham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antigen binding molecules, including antibodies, fragments, and variants thereof, that bind to the TNF-related cytokine LIGHT (TNFSF14). The present invention also relates to methods of use of such antigen binding molecules in treating and/or preventing inflammatory disorders and immune disorders."

The patent was filed on April 22, 2022, under Application No. 17/660,382...